Stock Price
2.21
Daily Change
0.09 4.25%
Monthly
-3.49%
Yearly
138.92%
Q3 Forecast
2.11

Mesoblast reported $48.24M in Operating Expenses for its fiscal semester ending in June of 2024.




Operating Expenses Change Date
Avita Medical AUD 28.36M 2.44M Dec/2024
Clinuvel Pharmaceuticals AUD 20.71M 2.35M Jun/2024
Cochlear AUD 897.2M 19.8M Dec/2024
CSL USD 5.72B 173M Dec/2024
Pacific Edge NZD 26.27M 12.77M Sep/2024
Paradigm Biopharmaceuticals AUD 6.36M 8.6M Dec/2024
PYC Therapeutics AUD 38.58M 20.29M Dec/2024
Ramsay Health Care AUD 8.35B 258.6M Dec/2024
Sonic Healthcare AUD 4.23B 2.14B Dec/2024
Starpharma Holdings AUD 7.82M 3.39M Dec/2024
Telix Pharmaceuticals AUD 191.9M 130.08M Dec/2024